This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
03 Sep 2013 | Global | Technology Research
Innovations in Allergy Treatment and Monitoring (Technical Insights)
Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy
The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...
$4,950.00 -
30 Apr 2013 | Global | Market Research
Outsourcing to CMOs in Emerging EconomiesBoon or Bane?
Analyzing the Prospects of CMOs in Emerging Markets
This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.
$1,500.00 -
09 Apr 2013 | Global | Market Research
The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?
European Biopharmaceutical Contract Manufacturing Market
This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.
$1,500.00 -
26 Mar 2013 | Global | Market Research
Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS
Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...
$1,500.00 -
21 Mar 2013 | Global | Market Research
Strategic Analysis of Anti-obesity Prescription Drug Development
Recent Marketing Approvals Revive Hope for Successful Treatment Options
This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...
$1,500.00 -
22 Feb 2013 | Global | Market Research
Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
Financial Management is the Key Strategy for Sustainability
This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...
$4,950.00 -
22 Feb 2013 | Global | Market Research
Overview of the Global Systemic Lupus Erythematosus Pipeline and the Next Three Potential Product Launches
This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.
$1,500.00 -
12 Feb 2013 | Global | Market Research
Analysis of the Paediatric Vaccines Market in Ethiopia, Tanzania, and Uganda
This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers How will Consumers Fare?, and Illumina's acquisition of GenoLogics.
$1,500.00 -
25 Jan 2013 | Global | Market Research
GIL-100 Sales and Investment Attractiveness Index for Healthcare
Country Attractiveness for Healthcare
Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging ...
$1,500.00
